{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:16:53Z","timestamp":1788553013177,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["09150182510016"],"award-info":[{"award-number":["09150182510016"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"ERC","doi-asserted-by":"publisher","award":["101001237"],"award-info":[{"award-number":["101001237"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cmi.2026.08.013","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:31:13Z","timestamp":1786721473000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunomodulating treatments for bacterial meningitis and viral encephalitis"],"prefix":"10.1016","author":[{"given":"Matthijs C.","family":"Brouwer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diederik","family":"van de Beek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2026.08.013_bib1","article-title":"Outcomes of adults with community-acquired bacterial meningitis in the Netherlands: A prospective nationwide cohort study","volume":"61","author":"Drost","year":"2026","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.cmi.2026.08.013_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.24802","article-title":"Global case fatality of bacterial meningitis during an 80-year period: A systematic review and meta-analysis","volume":"7","author":"van Ettekoven","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cmi.2026.08.013_bib3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1172\/JCI109850","article-title":"Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone","volume":"66","author":"Scheld","year":"1980","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cmi.2026.08.013_bib4","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0140-6736(21)00883-7","article-title":"Community-acquired bacterial meningitis","volume":"398","author":"van de Beek","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2026.08.013_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.74","article-title":"Community-acquired bacterial meningitis","volume":"2","author":"van de Beek","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.cmi.2026.08.013_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12974-015-0372-y","article-title":"Adjuvant treatment with dexamethasone plus anti-C5 antibodies improves outcome of experimental pneumococcal meningitis: A randomized controlled trial","volume":"12","author":"Kasanmoentalib","year":"2015","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.cmi.2026.08.013_bib7","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1172\/JCI57522","article-title":"Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis","volume":"121","author":"Woehrl","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cmi.2026.08.013_bib8","first-page":"198","article-title":"A double-blind study of the effectiveness of cortisol in the management of severe infections","volume":"75","author":"Bennett","year":"1962","journal-title":"Trans Assoc Am Physicians"},{"key":"10.1016\/j.cmi.2026.08.013_bib9","first-page":"CD004405","article-title":"Corticosteroids for acute bacterial meningitis","volume":"9","author":"Brouwer","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2026.08.013_bib10","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1473-3099(11)70055-X","article-title":"Slow initial beta-lactam infusion and oral paracetamol to treat childhood bacterial meningitis: A randomised, controlled trial","volume":"11","author":"Pelkonen","year":"2011","journal-title":"Lancet InfectDis"},{"key":"10.1016\/j.cmi.2026.08.013_bib11","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/INF.0000000000000122","article-title":"Glycerol and acetaminophen as adjuvant therapy did not affect the outcome of bacterial meningitis in Malawian children","volume":"33","author":"Molyneux","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2026.08.013_bib12","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/cid\/ciaa341","article-title":"Extended continuous beta-lactam infusion with oral acetaminophen in childhood bacterial meningitis: A randomized, double-blind clinical trial","volume":"72","author":"Savonius","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.013_bib13","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1474-4422(25)00454-5","article-title":"Safety and efficacy of adjunct dexamethasone in adults with herpes simplex virus encephalitis in the UK (DexEnceph): A multicentre, observer-blind, randomised, phase 3, controlled trial","volume":"25","author":"Solomon","year":"2026","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.cmi.2026.08.013_bib14","unstructured":"World Health Organization. WHO guidelines on meningitis diagnosis, treatment and care. Geneva, Switzerland; 2025. Report No.: CC BY-NC-SA 3.0."},{"key":"10.1016\/j.cmi.2026.08.013_bib15","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.cmi.2016.01.007","article-title":"ESCMID guideline: Diagnosis and treatment of acute bacterial meningitis","volume":"22","author":"van de Beek","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2026.08.013_bib16","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1086\/425368","article-title":"Practice guidelines for the management of bacterial meningitis","volume":"39","author":"Tunkel","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.013_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.q2452","article-title":"Meningitis ( bacterial) and meningococcal disease: recognition, diagnosis and management-summary of updated NICE guidance","volume":"387","author":"Paing","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2026.08.013_bib18","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJMoa021334","article-title":"Dexamethasone in adults with bacterial meningitis","volume":"347","author":"de Gans","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2026.08.013_bib19","article-title":"Community-acquired bacterial meningitis in adults in Denmark (2015-2023): A prospective, nationwide, population-based cohort study","volume":"64","author":"Nielsen","year":"2026","journal-title":"Lancet Reg Health Eur"},{"issue":"814","key":"10.1016\/j.cmi.2026.08.013_bib20","first-page":"e1","article-title":"Betamethasone and dexamethasone in adult community-acquired bacterial meningitis: a quality registry study from 1995 to 2014","volume":"22","author":"Glimaker","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2026.08.013_bib21","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cmi.2019.12.020","article-title":"Community-acquired bacterial meningitis in adults: in-hospital prognosis, long-term disability and determinants of outcome in a multicentre prospective cohort","volume":"26","author":"Tubiana","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2026.08.013_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-062698","article-title":"Clinical management of community-acquired meningitis in adults in the UK and Ireland in 2017: a retrospective cohort study on behalf of the National Infection Trainees Collaborative for Audit and Research (NITCAR)","volume":"12","author":"Ellis","year":"2022","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.cmi.2026.08.013_bib23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/cid\/ciab477","article-title":"Pneumococcal meningitis in adults: A prospective nationwide cohort study over a 20-year period","volume":"74","author":"Koelman","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.013_bib24","article-title":"Epidemiology, clinical features and outcome of adults with meningococcal meningitis: A 15-year prospective nationwide cohort study","volume":"30","author":"van Soest","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.cmi.2026.08.013_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101922","article-title":"Adjunctive dexamethasone treatment in adults with listeria monocytogenes meningitis: A prospective nationwide cohort study","volume":"58","author":"Brouwer","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.cmi.2026.08.013_bib26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1473-3099(15)00430-2","article-title":"Community-acquired bacterial meningitis in adults in the Netherlands, 2006-14: A prospective cohort study","volume":"16","author":"Bijlsma","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.013_bib27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S2352-4642(25)00029-X","article-title":"Adjunctive dexamethasone and 30-day all-cause death after hospital admission in paediatric pneumococcal meningitis: A propensity score analysis","volume":"9","author":"Giolito","year":"2025","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.cmi.2026.08.013_bib28","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s13054-016-1498-8","article-title":"Dramatic reduction of mortality in pneumococcal meningitis","volume":"20","author":"Buchholz","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2026.08.013_bib29","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S1473-3099(16)30521-7","article-title":"Clinical features and prognostic factors of listeriosis: The MONALISA national prospective cohort study","volume":"17","author":"Charlier","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.013_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/srep36996","article-title":"Bacterial meningitis in diabetes patients: A population-based prospective study","volume":"6","author":"van Veen","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.cmi.2026.08.013_bib31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11481-016-9705-6","article-title":"Bacterial meningitis in patients using immunosuppressive medication: A population-based prospective nationwide study","volume":"12","author":"van Veen","year":"2017","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.cmi.2026.08.013_bib32","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1212\/WNL.0000000000002315","article-title":"Community-acquired bacterial meningitis in adults with cancer or a history of cancer","volume":"86","author":"Costerus","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.cmi.2026.08.013_bib33","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1097\/00003246-200211000-00025","article-title":"Modulation of nuclear factor-kappaB activation and decreased markers of neurological injury associated with hypothermic therapy in experimental bacterial meningitis","volume":"30","author":"Irazuzta","year":"2002","journal-title":"Crit Care Med"},{"issue":"11","key":"10.1016\/j.cmi.2026.08.013_bib34","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1097\/01.CCM.0000095462.89651.9C","article-title":"Treatment of traumatic head injury--U.S.\/European guidelines or the Lund concept","volume":"31","author":"Naredi","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cmi.2026.08.013_bib35","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1001\/jama.2013.280506","article-title":"Induced hypothermia in severe bacterial meningitis: A randomized clinical trial","volume":"310","author":"Mourvillier","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2026.08.013_bib36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF01709471","article-title":"Prognostic factors associated with improved outcome of Escherichia coli bacteremia in a Finnish university hospital","volume":"16","author":"Kuikka","year":"1997","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.013_bib37","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s100960050164","article-title":"Factors associated with improved outcome of Pseudomonas aeruginosa bacteremia in a Finnish university hospital","volume":"17","author":"Kuikka","year":"1998","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.013_bib38","first-page":"725","article-title":"Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock 2026","volume":"54","author":"Prescott","year":"2026","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2026.08.013_bib39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF01646110","article-title":"[Immunoglobulins in the treatment of bacterial meningitis in childhood]","volume":"15","author":"Noack","year":"1987","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2026.08.013_bib40","first-page":"802","article-title":"[Immunoglobulins in bacterial and viral meningitis. Results of a controlled randomized clinical study of intravenous and intrathecal application]","volume":"100","author":"Neu","year":"1982","journal-title":"Fortschr Med"},{"key":"10.1016\/j.cmi.2026.08.013_bib41","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae131","article-title":"Adjunctive treatments for pneumococcal meningitis: A systematic review of experimental animal models","volume":"6","author":"Koning","year":"2024","journal-title":"Brain Commun"},{"key":"10.1016\/j.cmi.2026.08.013_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-073032","article-title":"Addition of daptomycin f or the treatment of pneumococcal meningitis: Protocol for the AddaMAP study","volume":"13","author":"Chavanet","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.cmi.2026.08.013_bib43","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0140-6736(71)91019-1","article-title":"Dexamethasone treatment in herpes-simplex encephalitis","volume":"1","author":"Upton","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2026.08.013_bib44","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0140-6736(72)90505-3","article-title":"Dexamethasone in herpes-simplex encephalitis","volume":"1","author":"Habel","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2026.08.013_bib45","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1007\/s00415-023-11715-0","article-title":"Steroids for the treatment of viral encephalitis: A systematic literature review and meta-analysis","volume":"270","author":"Hodzic","year":"2023","journal-title":"J Neurol"},{"key":"10.1016\/j.cmi.2026.08.013_bib46","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.cmi.2026.04.002","article-title":"Infectious encephalitis among adults: a prospective and population-based cohort study","volume":"32","author":"Duerlund","year":"2026","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2026.08.013_bib47","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2377-8-40","article-title":"Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): A multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933]","volume":"8","author":"Martinez-Torres","year":"2008","journal-title":"BMC Neurol"},{"key":"10.1016\/j.cmi.2026.08.013_bib48","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s42466-019-0031-3","article-title":"The German trial on Aciclovir and Corticosteroids in Herpes-simplex-virus-Encephalitis (GACHE): A multicenter, randomized, double-blind, placebo-controlled trial","volume":"1","author":"Meyding-Lamade","year":"2019","journal-title":"Neurol Res Pract"},{"key":"10.1016\/j.cmi.2026.08.013_bib49","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S1474-4422(25)00484-3","article-title":"Dexamethasone in herpes simplex virus encephalitis: timely insights amid study limitations","volume":"25","author":"Armangue","year":"2026","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.cmi.2026.08.013_bib50","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1093\/brain\/awad238","article-title":"Neurologic complications in herpes simplex encephalitis: Clinical, immunological and genetic studies","volume":"146","author":"Armangue","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.cmi.2026.08.013_bib51","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/infdis\/165.4.631","article-title":"Effect of high-dose dexamethasone on the outcome of acute encephalitis due to Japanese encephalitis virus","volume":"165","author":"Hoke","year":"1992","journal-title":"J Infect Dis."},{"key":"10.1016\/j.cmi.2026.08.013_bib52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00415-011-6118-6","article-title":"Japanese encephalitis (JE). Part I: clinical profile of 1,282 adult acute cases of four epidemics","volume":"259","author":"Sarkari","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.cmi.2026.08.013_bib53","doi-asserted-by":"crossref","first-page":"e667","DOI":"10.1093\/infdis\/jiaf601","article-title":"The impact of corticosteroid therapy on patients with West Nile Virus: A retrospective cohort study","volume":"233","author":"Poran","year":"2026","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.013_bib54","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijid.2021.10.002","article-title":"Characteristics and therapy of enteroviral encephalitis: Case report and systematic literature review","volume":"113","author":"Wagner","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.013_bib55","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s00415-021-10494-w","article-title":"Efficacy and safety of intravenous immunoglobulins for the treatment of viral encephalitis: a systematic literature review","volume":"269","author":"Wagner","year":"2022","journal-title":"J Neurol"},{"key":"10.1016\/j.cmi.2026.08.013_bib56","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/s41564-023-01405-y","article-title":"Modelling viral encephalitis caused by herpes simplex virus 1 infection in cerebral organoids","volume":"8","author":"Rybak-Wolf","year":"2023","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.cmi.2026.08.013_bib57","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.neulet.2004.06.064","article-title":"Increased presence of matrix metalloproteinases 2 and 9 in short- and long-term experimental herpes simplex virus encephalitis","volume":"368","author":"Martinez-Torres","year":"2004","journal-title":"Neurosci Lett"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X2600460X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X2600460X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:02:07Z","timestamp":1788552127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X2600460X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":57,"alternative-id":["S1198743X2600460X"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2026.08.013","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunomodulating treatments for bacterial meningitis and viral encephalitis","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2026.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}